Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: September 2011
-
By Kevin E. Noonan — The Federal Circuit reaffirmed the primacy of the factual disclosures used to establish obviousness, and how deficiencies thereof can defeat an obviousness claim, in reversing an invalidity determination in Star Scientific, Inc. v. R.J. Reynolds Tobacco Co. It also showed how persistently defendants pursue the tarnish of inequitable conduct even…
-
By Kevin E. Noonan — Yesterday, the Federal Circuit denied Plaintiffs' petition for panel rehearing in Association for Molecular Pathology v. U.S. Patent and Trademark Office. In their petition, counsel for Plaintiffs/Appellees asserted two grounds for rehearing, of points of law and fact overlooked or apprehended by the Court (see "Plaintiff(s) File Petition for Rehearing…
-
By Donald Zuhn — Earlier this year, the Intellectual Property Owners Association (IPO) released its 28th annual list of the top 300 organizations receiving U.S. patents. As in past years, Patent Docs used the IPO's list of top patent holders to compile a list of the top "biotech and pharma" companies and organizations receiving U.S.…
-
By Donald Zuhn — With the eighth round of negotiations of the Trans-Pacific Partnership (TPP) agreement currently underway in Chicago, a number of Senators have written to the U.S. Trade Representative, Ambassador Ron Kirk, to push for the inclusion of intellectual property provisions that are consistent with U.S. biologics exclusivity standards (i.e., 12 years of…
-
By Donald Zuhn — On Thursday, the Senate passed the House version of the Leahy-Smith America Invents Act (H.R. 1249) by an 89-9 vote (see "Senate Passes H.R. 1249"). The legislation now awaits the President's signature before becoming law. That signing could come as early as Monday, after the President spent Friday morning and early…
-
September 13, 2011 – Biotechnology/Chemical/ Pharmaceutical (BCP) Customer Partnership Meeting (U.S. Patent and Trademark Office) – Alexandria, VA (and webcast) September 14, 2011 – This Time It's Real — New U.S. Patent Reform Law Within Sight (Foley & Lardner) – 1:30 – 2:30 PM (ET) September 14, 2011 – Compulsory Licensing as an Emerging Global…
-
American Conference Institute (ACI) will be holding its 13th Advanced Forum on Biotech Patents on November 30 to December 1, 2011 in Boston, MA. The conference will allow attendees to: • Analyze the biosimilar approval pathway development process and get insight on the likely FDA regulations covering biosimilars;• Assess the impact patent reform is expected…
-
Foley & Lardner will be offering a web conference entitled "This Time It's Real — New U.S. Patent Reform Law Within Sight" on September 14, 2011 from 1:30 – 2:30 PM (ET). The web conference features USPTO Commissioner for Patents Robert L. Stoll (at right), and former USPTO Deputy Director Sharon R. Barner and Harold…
-
The Association of Intellectual Property Firms (AIPF) will be offering a webinar entitled "Optimizing Relations with the USPTO: All the Questions You Always Wanted to Ask and Could Never Get Answers For" on November 9, 2011 from 12:30 – 1:30 PM (EST). Stuart S. Levy of Sughrue Mion, PLLC and Jennifer C. Bailey of Hovey…
-
The American Bar Association (ABA) Section of Intellectual Property Law, Section of Public Contract Law, and Center for Continuing Legal Education will be offering a live webinar entitled "The Impact of Stanford v. Roche on Private Party Transactions: Inventor Ownership and Government Rights Under Bayh-Dole" on September 28, 2011 from 1:00 – 2:30 PM (Eastern). …
Patent Docs 